---
figid: PMC8558397__fonc-11-739648-g001
figtitle: 'Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the
  Challenges'
organisms:
- NA
pmcid: PMC8558397
filename: fonc-11-739648-g001.jpg
figlink: /pmc/articles/PMC8558397/figure/f1/
number: F1
caption: Detrimental gut microbial metabolites induce intestinal carcinogenesis. Various
  risk factors such as host genetics, obesity, and high-fat diet induce gut microbiota
  dysbiosis. Alteration of gut microbiota and its metabolites lead to mucus layer
  thickness reduction, high intestinal permeability and ensuing translocation of commensal
  microbiota and its metabolites. Maleficent bacteria overgrowth produces amounts
  of PAMPs like LPS to recognize the TLR4 of macrophages and dendritic cells, which
  then release certain proinflammatory cytokines (TNF-α, IL-1β, IL-23, etc.). Moreover,
  detrimental gut microbiota-derived metabolites such as secondary BAs, TMAO, H2S,
  and NOCs induce carcinogenesis through low-grade inflammation, immune escape, DNA
  damage, and activation of tumorigenic signals. Particularly, secondary BAs contribute
  to the progression of CRC via specific intracellular transduction pathways such
  as PKC-p38 MAPK signaling pathway, EGFR-ERK1/2 signaling pathway and Wnt/β-catenin
  signaling pathway. In addition to inducing ROS production, NOCs can involve in DNA
  damage by DNA alkylation and DNA adducts. AP-1, activator protein-1; APC, adenomatous
  polyposis coli; BAs, bile acids; CRC, colorectal cancer; CYP7A1, cholesterol 7 α
  hydroxylase; EGFR, epidermal growth factor receptor; ERK1/2, extracellular signal-regulated
  kinase 1/2; FMO, flavin monooxygenase; GSK3β, glycogen synthase kinase 3β; H2S,
  hydrogen sulfide; IL-1β, interleukin-1β; IL-23, interleukin-23; LEF, Lymphatic enhancement
  factor; LPS, lipopolysaccharide; NF-κB, factor-Kappa B; NOCs, N-nitroso compounds;
  p38 MAPK, p38 mitogen-activated protein kinase; PAMPs, pathogen-associated molecular
  patterns; PKC, protein kinase C; ROS, reactive oxygen species; TCF, T cell factor;
  TJ, tight junctions; TLR, Toll-like receptor; TMA, trimethylamine; TMAO, trimethylamine-N-oxide;
  TNF-α, tumor necrosis factor-α.
papertitle: 'Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and
  the Challenges.'
reftext: Wanru Zhang, et al. Front Oncol. 2021;11:739648.
year: '2021'
doi: 10.3389/fonc.2021.739648
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: colorectal cancer | gut microbiota | metabolites | tumor immunity | intracellular
  signal transduction
automl_pathway: 0.9275231
figid_alias: PMC8558397__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC8558397__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8558397__fonc-11-739648-g001.html
  '@type': Dataset
  description: Detrimental gut microbial metabolites induce intestinal carcinogenesis.
    Various risk factors such as host genetics, obesity, and high-fat diet induce
    gut microbiota dysbiosis. Alteration of gut microbiota and its metabolites lead
    to mucus layer thickness reduction, high intestinal permeability and ensuing translocation
    of commensal microbiota and its metabolites. Maleficent bacteria overgrowth produces
    amounts of PAMPs like LPS to recognize the TLR4 of macrophages and dendritic cells,
    which then release certain proinflammatory cytokines (TNF-α, IL-1β, IL-23, etc.).
    Moreover, detrimental gut microbiota-derived metabolites such as secondary BAs,
    TMAO, H2S, and NOCs induce carcinogenesis through low-grade inflammation, immune
    escape, DNA damage, and activation of tumorigenic signals. Particularly, secondary
    BAs contribute to the progression of CRC via specific intracellular transduction
    pathways such as PKC-p38 MAPK signaling pathway, EGFR-ERK1/2 signaling pathway
    and Wnt/β-catenin signaling pathway. In addition to inducing ROS production, NOCs
    can involve in DNA damage by DNA alkylation and DNA adducts. AP-1, activator protein-1;
    APC, adenomatous polyposis coli; BAs, bile acids; CRC, colorectal cancer; CYP7A1,
    cholesterol 7 α hydroxylase; EGFR, epidermal growth factor receptor; ERK1/2, extracellular
    signal-regulated kinase 1/2; FMO, flavin monooxygenase; GSK3β, glycogen synthase
    kinase 3β; H2S, hydrogen sulfide; IL-1β, interleukin-1β; IL-23, interleukin-23;
    LEF, Lymphatic enhancement factor; LPS, lipopolysaccharide; NF-κB, factor-Kappa
    B; NOCs, N-nitroso compounds; p38 MAPK, p38 mitogen-activated protein kinase;
    PAMPs, pathogen-associated molecular patterns; PKC, protein kinase C; ROS, reactive
    oxygen species; TCF, T cell factor; TJ, tight junctions; TLR, Toll-like receptor;
    TMA, trimethylamine; TMAO, trimethylamine-N-oxide; TNF-α, tumor necrosis factor-α.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - crc
  - cr-c
  - Calr
  - egr
  - bas
  - para
  - pyd3
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - Apc
  - Apc2
  - Axn
  - Fs(3)Apc
  - MKP-4
  - p38b
  - rl
  - lic
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - arm
  - Egfr
  - ras
  - Ras64B
  - Ras85D
  - AP-1gamma
  - Jra
  - kay
  - IRF6
  - IL37
  - IL23A
  - TNF
  - IL18
  - BAS
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - CD79A
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - APC
  - PROC
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - GRAP2
  - AHSA1
  - POLDIP2
  - CTNNB1
  - EGFR
  - KRAS
  - HRAS
  - NRAS
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
---
